e-learning
resources
Milan 2017
Sunday, 10.09.2017
Primary care diagnosis, assessment and management of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prediction of one or two years’ exacerbation free time in primary care COPD patients, a validated prediction nomogram
N. Abu Hussein (Basel, Switzerland)
Source:
International Congress 2017 – Primary care diagnosis, assessment and management of COPD
Session:
Primary care diagnosis, assessment and management of COPD
Session type:
Thematic Poster
Number:
929
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Abu Hussein (Basel, Switzerland). Prediction of one or two years’ exacerbation free time in primary care COPD patients, a validated prediction nomogram. 929
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
A 12-year-old male child with fever, productive cough and sudden onset paralysis
Related content which might interest you:
Impact of definition when assessing the cumulative incidence of exacerbation amongst a cohort of primary care COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 89s
Year: 2004
The impact of a definition when assessing the cumulative incidence of exacerbation for a primary care cohort of COPD patient
Source: Eur Respir J 2003; 22: Suppl. 45, 69s
Year: 2003
Detecting undiagnosed COPD: Using routine primary care data to select and validate candidate variables for COPD risk prediction
Source: Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care
Year: 2013
Validated the power of terminal status criteria in the prediction of 1-year mortality in patiens with COPD
Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care
Year: 2020
Association between chronic comorbidity and exacerbation rate in primary care COPD patients. Preliminary analysis of real-life general practice data (PROSPECT1)
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016
Validation of the COPD severity score for use in primary care: the NEREA study
Source: Eur Respir J 2009; 33: 519-527
Year: 2009
An integrated disease management (IDM) programme of 12 months duration was effective for patients with COPD
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016
FEV
1
does not predict the wider disability in patients with COPD referred from primary to secondary care
Source: Eur Respir J 2001; 18: Suppl. 33, 25s
Year: 2001
The evaluation of a tele-monitoring model (Teleheath) as an aid in the case management of patients with COPD
Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care
Year: 2012
Incidence and impact of healthcare defined exacerbation amongst a cohort of primary care COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 89s
Year: 2004
Comparison of characteristics of COPD patients with an established diagnosis, with those newly identified through case-finding – The Birmingham COPD cohort study
Source: International Congress 2014 – Highlights in respiratory epidemiology
Year: 2014
An RDW-based score predicts mid-term mortality in patients hospitalized with community acquired pneumonia (CAP): a derivation and validation study
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019
Introducing a new prognostic instrument for long-term mortality prediction among COPD patients - the CADOT index.
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019
Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up
Source: International Congress 2014 – Markers
Year: 2014
Direct cost analysis of COPD patients: A 1 year follow-up study
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
Reduction in acute hospital resource use by patients with severe COPD: an integrated facilitated care model
Source: Eur Respir J 2005; 26: Suppl. 49, 285s
Year: 2005
The outcome of patients with COPD admitted to UK hospitals with an exacerbation. Results from the RCP/BTS national COPD audit
Source: Annual Congress 2005 - COPD - acute exacerbations
Year: 2005
COPD related fatigue (COPD-RF) as a patient centred outcome tool in COPD: Various predictors and its correlation with other outcome parameters
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016
A clinical prediction model to support asthma diagnosis in children and young people in UK primary care
Source: Virtual Congress 2021 – Highlights for primary care in 2021
Year: 2021
Health status predicts long-term outcomes in patients with chronic obstructive pulmonary disease (COPD): Pooled analysis of patient-level data from the COPD biomarker qualification consortium database
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept